Investigating Inherited Causes in Patients Presenting with Thrombophilia

Authors

  • Maymoona Suhail Department of Haematology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
  • Mehreen Khalid Department of Haematology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
  • Asad Mahmood Department of Haematology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
  • Hamid Saeed Malik Department of Haematology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
  • Rafia Mahmood Department of Haematology, Armed Forces Institute of Pathology, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan
  • Muhammad Saleem Bajwa Combined Military Hospital, Rawalpindi/National University of Medical Sciences (NUMS) Pakistan

DOI:

https://doi.org/10.51253/pafmj.v75i6.9671

Keywords:

Heritability, Thromboembolism, Thrombophilia

Abstract

Objective: To determine the frequency of different causes of inherited thrombophilia and evaluate clinical presentations in patients presenting with documented venous or arterial thrombosis.

Study Design: Cross-sectional study.

Place and Duration of Study: Armed Forces Institute of Pathology Rawalpindi, Pakistan from Jan to Jun 2022.

Methodology: One hundred and seven patients who fulfilled the selection criteria and gave informed consent in written form were enrolled. Clinical presentations were noted down and patients were assessed for inherited thrombophilia. Polymerase chain reaction was used for the detection of factor V Leiden mutation and prothrombin gene mutation. Pro C global clotting based screening test was used to determine the anticoagulatory capacity of protein C and S. Quantitative determination of the functional activity of antithrombin was performed on CS5100 automated coagulation analyzer.

Results: The mean age of the patients was 29.31±14.17 years. Inherited thrombophilia was present in 26(24.3%) patients. Factor V Leiden mutation was present in 14(53.8%), antithrombin deficiency in 6(23.1%), protein C deficiency in 3(11.5%), protein S deficiency in 2(7.7%) and prothrombin gene mutation in 1(3.9%) patient. Commonest clinical presentation was deep venous thrombosis in 10(38.5%) patients followed by pulmonary embolism in 5(19.2%), portal vein thrombosis in 3(11.5%), superficial venous thrombosis in 3(11.5%).

Conclusion: The commonest inherited cause of thrombophilia was factor V Leiden mutation and the commonest presenting complaint was deep venous thrombosis.

Downloads

Download data is not yet available.

References

REFERENCES

1. Piran S., Schulman S. Management of venous thromboembolism: an update. Thromb J 2016; 14(1): 23.

https://doi.org/10.1186/s12959-016-0107-z

2. Margaglione M, Antonucci E, D’Andrea G, Migliaccio L, Ageno W, Bucherini E, et al. Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study. Blood Transfus 2020; 18(6): 486–495. https://doi.org/10.2450/2020.0091-20

3. Stone J, Hangge P, Albadawi H, Wallace A, Shamoun F, Knuttien MG, et al. Deep vein thrombosis: pathogenesis, diagnosis, and medical management. Cardiovasc Diagn Ther 2017; 7(Suppl 3): 276-284.

https://doi.org/10.21037/cdt.2017.09.01

4. Hamidpour M, Ghorbani M, Rezaei-Tavirani M, Niazkar HR, Managhchi MR, Shahrudian M. Factor V Leiden, MTHFR C677T and prothrombin gene mutation G20210A in Iranian patients with venous thrombosis. Iran J Blood Cancer 2019; 11(3): 91-95.

http://ijbc.ir/article-1-888-en.html

5. Ahangari N, Doosti M, Mousavifar N, Attaran M, Shahrokhzadeh S, Memarpour S, et al. Hereditary thrombophilia genetic variants in recurrent pregnancy loss. Arch Gynecol Obstet 2019; 300(3): 777-782.

https://doi.org/10.1007/s00404-019-05224-7

6. Liu X, Chen Y, Ye C, Xing D, Wu R, Li F, et al. Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod 2021; 36(5): 1213-1229.

https://doi.org/10.1093/humrep/deab010

7. Ali N, Bhatti FA, Khan SA. Frequency of hereditary thrombophilia in women with recurrent pregnancy loss in Northern Pakistan. J Obstet Gynaecol 2014; 40(6): 1561-1566.

https://doi.org/10.1111/jog.12385

8. Khalid S, Sajid R, Adil S, Khurshid M. Frequency of hereditary thrombophilia: an AKUH experience. J Pak Med Assoc 2004; 54(8): 427.

9. Khan M, Altaf C, Saeed Malik H, Abdul Naeem M, Latif A. Heritable Thrombophilia in Venous Thromboembolism in Northern Pakistan: A Cross-Sectional Study. Advanc Hematol 2021; 2021: 8317605.

https://doi.org/10.1155%2F2021%2F8317605

10. Mitriuc D, Popuşoi O, Catrinici R, Friptu V. The obstetric complications in women with hereditary thrombophilia. Med Pharm Rep 2019; 92(2): 106-110.

https://doi.org/10.15386/cjmed-1097

11. Raslan O, Tran C, Al-Ani F, Sposato L, Lazo-Langner A. Prevalence of Thrombophilia in Transient Ischemic Attack and Ischemic Stroke Patients. Blood 2020; 136(1): 3-10.

https://doi.org/10.1182/blood-2020-133476

12. Dautaj A, Krasi G, Bushati V, Precone V, Gheza M, Fioretti F, et al. Hereditary thrombophilia. Acta BioMed 2019; 90(Suppl 10): 44-46. https://doi.org/10.23750/abm.v90i10-s.8758

13. Sridharan M, Coon LM, Chen D, Pruthi RK. Factor V deficiency with a thrombotic clinical phenotype. Semin Thromb Hemost 2019; 45(1): 108-112. https://doi.org/10.1055/s-0038-1677041

14. Maruyama K, Kokame K. Carrier frequencies of antithrombin, protein C, and protein S deficiency variants estimated using a public database and expression experiments. Res Pract Thromb Haemost 2021; 5(1): 179-186. https://doi.org/10.1002/rth2.12456

15. Dinarvand P, Moser KA. Protein C deficiency. Arch Pathol Lab Med 2019; 143(10): 1281-1285.

https://doi.org/10.5858/arpa.2017-0403-RS

16. Linnemann B, Hart C. Laboratory diagnostics in thrombophilia. Hämostaseologie 2019; 39(1): 49-61.

17. Cheves TA, DeMarinis S, Sweeney JD. Laboratory Methods in the Assessment of Hereditary Hemostatic Disorders. Hematol Oncol Clin 2021; 35(6): 1051-1068.

https://doi.org/10.1016/j.hoc.2021.07.002

18. Bravo-Pérez C, Vicente V, Corral J. Management of antithrombin deficiency: an update for clinicians. Expert Rev Hematol 2019; 12(6): 397-405. https://doi.org/10.1080/17474086.2019.1611424

19. Abughanimeh OK, Marar RI, Tahboub M, Kaur A, Qasrawi A, Ghanimeh MA, et al Hereditary Thrombophilia Testing Among Hospitalized Patients: Is It Warranted? Cureus 2022; 14(5): e24855. https://doi.org/10.7759/cureus.24855

20. Olivo Freites C, Naymagon L. The utility of hereditary thrombophilia testing among patients with unprovoked venous thromboembolism. Int J Lab Hematol 2022; 44(2): 393-398.

https://doi.org/10.1111/ijlh.13752

21. Campello E, Spiezia L, Adamo A, Simioni P. Thrombophilia, risk factors and prevention. Expert Rev Hematol 2019; 12(3): 147-158.

https://doi.org/10.1080/17474086.2019.1583555

Downloads

Published

31-12-2025

Issue

Section

Original Articles

How to Cite

1.
Suhail M, Khalid M, Mahmood A, Malik HS, Mahmood R, Bajwa MS. Investigating Inherited Causes in Patients Presenting with Thrombophilia. Pak Armed Forces Med J [Internet]. 2025 Dec. 31 [cited 2026 Jan. 2];75(6):1065-9. Available from: https://pafmj.org/PAFMJ/article/view/9671